Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine, Aichi, Japan.
J Diabetes Investig. 2024 Oct;15(10):1347-1354. doi: 10.1111/jdi.14283. Epub 2024 Aug 8.
Advances in diabetes medication and population aging are lengthening the lifespans of people with diabetes mellitus (DM). Older patients with diabetes mellitus often have multimorbidity and tend to have polypharmacy. In addition, diabetes mellitus is associated with frailty, functional decline, cognitive impairment, and geriatric syndrome. Although the numbers of patients with frailty, dementia, disability, and/or multimorbidity are increasing worldwide, the accumulated evidence on the safe and effective treatment of these populations remains insufficient. Older patients, especially those older than 75 years old, are often underrepresented in randomized controlled trials of various treatment effects, resulting in limited clinical evidence for this population. Therefore, a deeper understanding of the characteristics of older patients is essential to tailor management strategies to their needs. The clinical guidelines of several academic societies have begun to recognize the importance of relaxing glycemic control targets to prevent severe hypoglycemia and to maintain quality of life. However, glycemic control levels are thus far based on expert consensus rather than on robust clinical evidence. There is an urgent need for the personalized management of older adults with diabetes mellitus that considers their multimorbidity and function and strives to maintain a high quality of life through safe and effective medical treatment. Older adults with diabetes mellitus accompanied by frailty, functional decline, cognitive impairment, and multimorbidity require special management considerations and liaison with both carers and social resources.
糖尿病药物的进步和人口老龄化延长了糖尿病患者的寿命。患有糖尿病的老年患者往往患有多种疾病,并倾向于使用多种药物。此外,糖尿病与虚弱、功能下降、认知障碍和老年综合征有关。尽管全球患有虚弱、痴呆、残疾和/或多种疾病的患者人数正在增加,但关于这些人群安全有效治疗的累积证据仍然不足。在各种治疗效果的随机对照试验中,年龄较大的患者,尤其是 75 岁以上的患者往往代表性不足,导致针对这一人群的临床证据有限。因此,深入了解老年患者的特点对于根据他们的需求制定管理策略至关重要。几个学术协会的临床指南已经开始认识到放宽血糖控制目标以预防严重低血糖和维持生活质量的重要性。然而,目前血糖控制水平是基于专家共识,而不是基于可靠的临床证据。迫切需要对患有糖尿病的老年人进行个性化管理,考虑到他们的多种疾病和功能,并通过安全有效的医疗努力努力维持高质量的生活。伴有虚弱、功能下降、认知障碍和多种疾病的老年糖尿病患者需要特殊的管理考虑,并与护理人员和社会资源保持联系。